These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35624589)

  • 1. HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System.
    Fellinger P; Rodewald K; Ferch M; Itariu B; Kautzky-Willer A; Winhofer Y
    Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Maffeis C
    Pediatr Diabetes; 2022 Feb; 23(1):84-89. PubMed ID: 34888998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis.
    Perlman JE; Gooley TA; McNulty B; Meyers J; Hirsch IB
    Diabetes Technol Ther; 2021 Apr; 23(4):253-258. PubMed ID: 33253015
    [No Abstract]   [Full Text] [Related]  

  • 4. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
    Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
    J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes.
    Fang M; Wang D; Rooney MR; Echouffo-Tcheugui JB; Coresh J; Aurora RN; Punjabi NM; Selvin E
    Clin Chem; 2023 Apr; 69(4):422-428. PubMed ID: 36738249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Management Indicator for People with Type 1 Asian Diabetes Is Different from That of the Published Equation: Differences by Glycated Hemoglobin Distribution.
    Yoo JH; Yang SH; Kim G; Kim JH
    Diabetes Technol Ther; 2021 Nov; 23(11):745-752. PubMed ID: 34160289
    [No Abstract]   [Full Text] [Related]  

  • 7. An Examination of the Glucose Management Indicator in Young Children with Type 1 Diabetes.
    Monzon AD; Patton SR; Clements M
    J Diabetes Sci Technol; 2022 Nov; 16(6):1505-1512. PubMed ID: 34098763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
    Toschi E; Michals A; Adam A; Davis D; Atakov-Castillo A; Slyne C; Munshi M
    Diabetes Care; 2021 Dec; 44(12):2787-2789. PubMed ID: 34635503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
    Chrzanowski J; Michalak A; Łosiewicz A; Kuśmierczyk H; Mianowska B; Szadkowska A; Fendler W
    Diabetes Technol Ther; 2021 Apr; 23(4):293-305. PubMed ID: 33112161
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin.
    Gomez-Peralta F; Choudhary P; Cosson E; Irace C; Rami-Merhar B; Seibold A
    Diabetes Obes Metab; 2022 Apr; 24(4):599-608. PubMed ID: 34984825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Jan; 16(1):113-119. PubMed ID: 33269634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes.
    Shah VN; Vigers T; Pyle L; Calhoun P; Bergenstal RM
    Diabetes Technol Ther; 2023 May; 25(5):324-328. PubMed ID: 36790875
    [No Abstract]   [Full Text] [Related]  

  • 15. Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study.
    Al Hayek AA; Sobki SH; Al-Saeed AH; Alzahrani WM; Al Dawish MA
    Diabetes Ther; 2022 May; 13(5):953-967. PubMed ID: 35306640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Calculation of the Glucose Management Indicator Is Influenced by the Continuous Glucose Monitoring System and Patient Race.
    Angellotti E; Muppavarapu S; Siegel RD; Pittas AG
    Diabetes Technol Ther; 2020 Sep; 22(9):651-657. PubMed ID: 31821016
    [No Abstract]   [Full Text] [Related]  

  • 17. [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus].
    Peng HM; Deng HR; Zhou YW; Wang CF; Lyu J; Mai XD; Yang DZ; Lu J; Xu W; Yan JH
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1190-1195. PubMed ID: 35462500
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the Glucose Management Indicator Using Different Sampling Durations.
    Bailey R; Calhoun P; Bergenstal RM; Beck RW
    Diabetes Technol Ther; 2023 Feb; 25(2):148-150. PubMed ID: 36130138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.
    Franceschi R; Cauvin V; Stefani L; Berchielli F; Soffiati M; Maines E
    Front Endocrinol (Lausanne); 2022; 13():907517. PubMed ID: 35784525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of continuous glucose monitoring-derived person-specific HbA1c in the presence and absence of complications in type 1 diabetes.
    Xu Y; Oriot P; Dunn TC; Hermans MP; Ram Y; Cheng A; Ajjan RA
    Diabetes Obes Metab; 2022 Dec; 24(12):2383-2390. PubMed ID: 35876223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.